Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
-873
-
Total reported value, excl. options
-
$140M
-
Value change
-
-$332K
-
Number of buys
-
15
-
Number of sells
-
-22
-
Price
-
$13.66
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q3 2021
45 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 44.5M outstanding shares and own 22.99% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.03M shares), Essex Woodlands Management, Inc. (1.83M shares), RTW INVESTMENTS, LP (1.39M shares), PURA VIDA INVESTMENTS, LLC (581K shares), Opaleye Management Inc. (443K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (393K shares), COWEN AND COMPANY, LLC (392K shares), VANGUARD GROUP INC (354K shares), ARMISTICE CAPITAL, LLC (348K shares), and Pentwater Capital Management LP (311K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.